PSC
Portman Square Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.27M | Sell |
6,967
-5,562
| -44% | -$1.81M | 0.07% | 21 |
|
|
2025
Q1 | $3.38M | Sell |
12,529
-410
| -3% | -$111K | 0.09% | 26 |
|
|
2024
Q4 | $3.04M | Buy |
12,939
+4,426
| +52% | +$1.04M | 0.11% | 15 |
|
|
2024
Q3 | $2.34M | Sell |
8,513
-3,335
| -28% | -$917K | 0.09% | 22 |
|
|
2024
Q2 | $2.88M | Sell |
11,848
-4,175
| -26% | -$1.01M | 0.1% | 16 |
|
|
2024
Q1 | $2.39M | Buy |
16,023
+10,060
| +169% | +$1.5M | 0.07% | 15 |
|
|
2023
Q4 | $1.14M | Sell |
5,963
-5,951
| -50% | -$1.14M | 0.03% | 46 |
|
|
2023
Q3 | $2.11M | Buy |
11,914
+2,146
| +22% | +$380K | 0.05% | 58 |
|
|
2023
Q2 | $1.86M | Buy |
9,768
+4,876
| +100% | +$926K | 0.05% | 37 |
|
|
2023
Q1 | $980K | Buy |
+4,892
| New | +$980K | 0.05% | 57 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 112 |
|